Stanley, C. P., Hind, W. H., Tufarelli, C., & O’Sullivan, S. E. (2016). The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries. Pharmacol Res.
Dyfyniad Arddull ChicagoStanley, Christopher P., William H. Hind, Christina Tufarelli, and Saoirse E. O’Sullivan. "The Endocannabinoid Anandamide Causes Endothelium-dependent Vasorelaxation in Human Mesenteric Arteries." Pharmacol Res 2016.
Dyfyniad MLAStanley, Christopher P., William H. Hind, Christina Tufarelli, and Saoirse E. O’Sullivan. "The Endocannabinoid Anandamide Causes Endothelium-dependent Vasorelaxation in Human Mesenteric Arteries." Pharmacol Res 2016.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.